OBJECTIVE: to evaluate efficacy of Cyberknife radiosurgery in survival of patients with glioblastoma recurrent. MATERIAL AND METHODS: 15 patients with glioblastoma recurrent were treated with staged radiosurgery in May 2004 - January 2006. The mean KPS was 70. The median prescribed isodose was 75% and the median mean dose was 24 Gy in 3 fractions. RESULTS: The mean survival time is 20 months. No acute toxicity was observed. At 15 months from the date of radiosurgery one case of radionecrosis was detected. CONCLUSIONS: our study population confirms that staged radiosurgery is effective in local treatment of recurrent GBM without major acute toxicities.
|Translated title of the contribution||Radiosurgery Cyberknife in high grade gliomas|
|Number of pages||4|
|Publication status||Published - Mar 2007|
ASJC Scopus subject areas